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Background Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is a systemic inflammatory
process predominantly affecting upper and lower respiratory tract and kidneys. Valvular heart disease is a rare
manifestation of GPA.
...................................................................................................................................................................................................
Case summary We report two cases of acute valvular heart disease mimicking acute endocarditis caused by GPA. Both patients were
middle-aged females with acute aortic valve regurgitation suggestive of possible infective endocarditis. In their recent
medical history, atypical otitis and sinusitis were noted. The first patient was admitted with heart failure and the second
patient because of persisting fever. Echocardiogram revealed severe aortic regurgitation with an additional structure on
two cusps, suggestive of infective endocarditis in both patients. Urgent surgical replacement was performed; however,
intraoperative findings did not show infective endocarditis, but severe inflammatory changes of the valve and surround-
ing tissue. In both patients, the valve was replaced by a prosthetic valve. Microscopic examination of the valve/myocar-
dial biopsy showed diffuse acute and chronic inflammation with necrosis and necrotizing granulomas, compatible with
GPA after infectious causes were excluded. Disease remission was obtained in both patients, in one patient with
Rituximab and in the other with Glucocorticoids and Cyclophosphamide. Both had an uneventful follow-up.
...................................................................................................................................................................................................
Discussion Granulomatosis with polyangiitis can be a rare cause of acute aortic valve regurgitation mimicking infective endo-
carditis with the need for surgical valve replacement. Atypical ear, nose, and throat symptoms can be a first sign of
GPA. Symptom recognition is important for early diagnosis and appropriate treatment to prevent further progres-
sion of the disease.
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Learning points
• Granulomatosis with polyangiitis (GPA) can be a rare cause of acute aortic valve regurgitation mimicking infective endocarditis and can ne-
cessitate aortic valve replacement.
• Clinical presentation of GPA is often insidious and lesions of ear, nose, and throat, lung, and/or kidney are most frequently seen. Symptom
recognition is important for early diagnosis and appropriate treatment to prevent further progression of the disease.
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Granulomatosis with polyangiitis (GPA), formerly known as
Wegener’s granulomatosis, is a form of anti-neutrophil cytoplasmic
antibody (ANCA) associated vasculitis (AAV). AAV is a necrotizing
vasculitis predominantly affecting small vessels and associated with
ANCAs specific for myeloperoxidase (MPO-ANCA) or proteinase 3
(PR3-ANCA). Granulomatosis with polyangiitis is characterized by
necrotizing granulomatous inflammation predominantly affecting
small to medium vessels of the upper and lower respiratory tract and
kidneys.1 Cardiac involvement is rather rare in GPA, however cardiac
manifestations such as pericarditis, coronary arteritis, myocarditis,
arrhythmias, and valvulitis have been described occasionally.2–5
Valvular disease is rarely reported and the valvular lesion is usually
isolated, with aortic valve regurgitation being the most frequent find-
ing.5–7 We report two cases of severe acute aortic valve regurgita-
tion, both caused by aortic valve infiltration due to GPA,
necessitating surgical replacement. The purpose of this case report is
to remind clinicians that GPA can be a cause of acute aortic valve in-
sufficiency and atypical ear, nose, and throat (ENT) symptoms can be




A 58-year-old woman with 3 years history of recurrent episodes of
otitis media with effusion and persistent hearing loss, for which bilat-
eral tympanostomy tubes were placed. Bilateral peripheral pulmon-
ary embolisms were also noted in her medical history. Recently, she
was referred to a rheumatologist because of slightly elevated inflam-
matory blood markers. Further tests showed an ANF of 1/320 (<1/
80) with anti-Sjögren’s syndrome-related antigen A antibodies of
more than 640 kU/L (<10), and positive ANCAs [pANCAs: 1/320
and anti-MPO: 60.4 kU/L (<10)]. The tests suggested autoimmunity
for which therapy with hydroxychloroquine was started. However,
due to side-effects treatment was stopped after 3 days. Later on, she
was hospitalized because of exertional dyspnoea without orthop-
noea. Physical examination revealed no abnormalities except for
bibasal crepitus upon auscultation. There was a discretely elevated
C-reactive protein (CRP) of 13 mg/L (<3.0) and D-dimers were
1437 ng/mL (0–500). Bilateral ground-glass opacities were seen in
both lower lung lobes (Figure 1). Bronchoalveolar lavage isolated a
methicillin-sensitive Staphylococcus aureus, for which no antibiotic
treatment was deemed necessary. Transthoracic echocardiography
(TTE) revealed a slight decrease of the systolic left ventricular func-
tion, a mild aortic regurgitation, a moderate mitral valve insufficiency,
and a moderate tricuspid valve insufficiency. A moderate pulmonary
hypertension with pulmonary artery pressure of 52 mmHg was
measured. A first-degree atrioventricular (AV) block (PR interval 298
ms) and a prolonged QT (526 ms) were observed on electrocardio-
gram. Therapy with spironolactone and furosemide was started, and
she was discharged after 8 days. After a short clinical improvement,
an acute deterioration with nausea and exertional dyspnoea upon
minimal effort was seen. A new diastolic murmur and bibasal crepita-
tions were noticed. Blood pressure measured 120/50 mmHg, heart
rate 88 b.p.m. and jugular venous pressure (JVP) was 6 cm above the
sternal angle. Laboratory findings showed an erythrocyte sedimenta-
tion rate of 48 mm/h (0–30), a normal white blood count, minimally
elevated CRP of 7.2 mg/L (<3.0), a raised serum creatinine of
1.13 mg/dL (0.55–1.02), and a N-terminal pro B-type natriuretic pep-
tide of 7237 pg/mL (0–125). Transoesophageal echocardiography
(TOE) showed a left ventricular ejection fraction of 53%, a severe
aortic regurgitation with a new additional structure seen at the level
of the non-coronary cusp (8 mm), and thickening of the right coron-
ary cusp (RCC, 3 mm), and the aortomitral continuity (7 mm)
(Figure 2 and Video 1). The insufficiencies of the mitral and tricuspid
valve were assessed slightly worse than before and pulmonary hyper-
tension was also increased. The tentative diagnosis of infective
Events—Case 1
2016 Bilateral tympanostomy tubes.
October 2018 Bilateral peripheral pulmonary embolisms.
October 2019 Referral to rheumatologist and treatment with




Hospitalization due to heart failure.
15 November
2019
Readmission because of exertional dyspnoea




Aortic valve replacement with mitral and tricus-
pid valve annuloplasty.
January 2020 Start treatment with Rituximab because of
granulomatosis with polyangiitis (GPA).
March 2020 No more GPA disease activity.
Events—Case 2
June 2015 Functional endoscopic sinus surgery and bilat-
eral tympanostomy tubes.
25 July 2015 Hospitalization with tentative diagnosis of in-
fective endocarditis.
11 August 2015 Persistent moderate aortic valve regurgitation
with thickened aortic valve leaflets and a
thickening of the aortomitral continuity.
13 August 2015 Aortic valve replacement.





Start corticoid and cyclophosphamide therapy
because of GPA.
4 years of fol-
low-up
Non-evolving, minimal paravalvular regurgita-
tion, without GPA disease activity.
Continued























































.. endocarditis was made and an empirical antibiotic therapy with ampi-
cillin (6 2 g IV), flucloxacillin (6 2 g IV), and gentamycin (1 240
mg IV) was started immediately. During hospitalization, an episode of
paroxysmal atrial fibrillation with spontaneous conversion to sinus
rhythm was observed. She was transferred to our centre in a stable
condition 3 days later and scheduled for surgery. Coronary artery
imaging was not performed prior to surgery. Intraoperative findings
did not show endocarditis but a pronounced thickening and oedema
of the non-coronary and RCC (Figure 3). The mitral and tricuspid
valves were inspected but no abnormalities were seen. An aortic
valve replacement was performed with a 25 mm mechanical valve
and a mitral and tricuspid valve annuloplasty with a 28 mm and
30 mm ring, respectively. The procedure was uneventful.
Anatomopathological findings of the aortic valve included diffuse ac-
tive and chronic inflammation with necrotizing granulomas, suggest-
ive for GPA after exclusion of infection with micro-organisms (Figures
4 and 5). Intraoperative cultures were negative and all blood cultures
also remained negative. Postoperative course was uneventful and the
patient was discharged 7 days after surgery. Rituximab was adminis-
trated at 6 and 8 weeks after surgery and Methotrexate (15 mg/
week) was started 3 months after surgery. During the follow-up
period of 6 months, no more disease activity was seen. Inflammatory
markers and kidney function remained normal and TTE showed a
normal systolic function and a normal function of the valves.[AQ:
Please spell out ANF (if necessary).]
Patient 2
The second patient was a 72-year-old woman. In her medical history,
a functional endoscopic sinus surgery was performed because of per-
sisting sinusitis, and she had tympanostomy tubes placed because of
Figure 2 Transoesophageal echocardiography in Patient 1. (A) Mid-oesophageal right ventricular inflow–outflow view showing thickened aortic
valve leaflets with an additional structure at level of the non- and right coronary cusp. (B) Mid-oesophaegeal aortic valve long-axis view showing thick-
ening of the aortic sinus in continuity with the base of the anterior mitral leaflet. Ao, aorta; LA, left atrium; lc, left coronary sinus and cusp; LV, left ven-
tricle; nc, non-coronary; rc, right coronary; RV, right ventricle.
Figure 1 Bilateral ground-glass opacities on computed tomog-
raphy thorax in Patient 1 (blue arrows).



































































recurrent otitis media with effusion. There were no cardiovascular
risk factors. She was admitted to the internal medicine department
with complaints of increased fatigue, dizziness, and persistent fever
for 2 months. Clinical examination showed a blood pressure of 130/
76 mmHg, a heart rate of 74 b.p.m., and a JVP of 6 cm above the ster-
nal angle. A diastolic murmur was noticed and lung auscultation was
normal. Initial laboratory results showed an elevated erythrocyte
sedimentation rate of 114 mm/u (0–30), a slightly elevated white
blood cell count of 10.99 10E3/mL (3.65–9.30), and a CRP level ele-
vated up to 122 mg/L (<5.0). Serum creatinine level was 0.61 mg/dL
(0.55–0.96). Computed tomography (CT) scan of the sinuses showed
a bilateral maxillary sinusitis, CT scans of thorax and abdomen were
negative. TOE showed normal atria and ventricles with a normal sys-
tolic function. A tricuspid aortic valve was seen with moderate aortic
valve regurgitation, thickened leaflets and an additional structure at
the level of the left and RCC. There was a maximal gradient of
32 mmHg and a mean gradient of 17 mmHg across the valve. The
thickening of the aortic sinus continued to the base of the anterior
mitral leaflet and a moderate mitral valve insufficiency was seen.
Pulmonary valve and tricuspid valve were normal (Figure 6 and Video
2). Although blood cultures remained negative, a tentative diagnosis
of infective endocarditis was made and treatment for endocarditis
was started with ampicillin (6 2 g), oxacillin (6 2 g), and gentamy-
cin (1 450 mg). On a new ultrasound an expansion of the thicken-
ing was seen (aortomitral continuity 17 mm  9 mm; RCC 9 mm).
Antibiotic therapy was empirically switched to vancomycin (1.8 mg/
day continuous infusion) and gentamycin (600 mg/day) and patient
was scheduled for surgery (20 days after initial antibiotic therapy).
Coronary artery imaging was not performed prior to surgery.
Intraoperative findings did not show endocarditis, but a massive infil-
tration of the ventricular side of the right and left coronary cusp was
seen, expanding towards the apex in the interventricular septum, be-
tween pulmonary artery and aortic base, and towards the base of the
mitral valve. An aortic valve replacement was performed with a
23 mm biological valve. Mitral valve replacement was not performed.
The procedure was uneventful. Due to a persistent third-degree AV
block, a dual-chamber pacemaker was placed on the 11th postopera-
tive day. Anatomopathological findings of the valve showed a valvular
and subvalvular pseudotumour caused by GPA, with necrotizing
granulomas (Figure 7). Microscopic findings of the myocardial biopsy
showed a mixed inflammatory process as well as necrosis and mul-
tiple, small necrotizing granulomas. The patient was discharged on
postoperative Day 15; however, on postoperative Day 26, she was
readmitted because of a persisting fever. Investigations showed in-
flammatory blood result with an elevated erythrocyte sedimentation
rate of 87 mm/h (0–30), CRP of 157 mg/L (<0.5), and white blood
cell count of 13.41  10E3/mL (3.65–9.30). There was a positive
ANCA result with slightly elevated anti-MPO titer up to 5.8 IU/mL.
Therapy with Methylprednisolone (32 mg daily) was started, resulting
in a good clinical and biochemical response. Two weeks later,
Cyclophosphamide was started (6 cycles of 500 mg, with 2 weeks
Figure 4 Histopathology of the aortic valve in Patient 1: geo-
graphic necrosis (arrows) (haematoxylin and eosin staining, original
magnification200).
Figure 5 Histopathology of the aortic valve in Patient 1: small
granuloma (arrows) (haematoxylin and eosin staining, original mag-
nification400).
Figure 3 Macroscopic view of thickened and inflamed aortic
valve leaflet in Patient 1.













interval), followed by a maintenance therapy of Azathioprine (50 mg,
twice daily) and a corticoid tapering schedule (10% per month). With
this therapy no GPA-activity was seen: patient had no complaints, in-
flammatory markers and kidney function remained normal. Cardiac
evolution initially showed a thickening at the level of the left coronary
cusp with a mild paravalvular regurgitation. After 4 years of follow-
up, no evolution of the aortic regurgitation and no more GPA activity
were noted.
Discussion
Granulomatosis with polyangiitis, formerly known as Wegener’s
granulomatosis, is typically characterized by inflammation of the re-
spiratory tract and by glomerulonephritis. Cardiac lesions previously
thought as rather rare in GPA, may be more frequent than expected,
ranging from 6% to 44% in the literature.2,8 Granulomatosis with pol-
yangiitis can cause pericarditis, coronary arteritis, myocarditis, valvul-
itis, and arrhythmias.8
We reviewed two cases transferred to our centre because of sus-
picion of infective endocarditis with de novo aortic regurgitation. In
both patients, infective endocarditis was a possible diagnosis, but
major criteria for infective endocarditis were doubtful. On the ultra-
sound, there was mainly a thickening of the leaflets and surrounding
Figure 7 Microscopy of the aortic valve in Patient 2, demonstrat-
ing a necrotizing granuloma with surrounding acute and chronic in-
flammatory infiltrate (arrows) (haematoxylin and eosin staining,
original magnification200).
Video 1 Transoesophageal echocardiography in Patient 1. Mid-
oesophaegeal aortic valve long-axis view showing thickening of the
aortic sinus in continuity with the base of the anterior mitral leaflet.
Video 2 Transoesophageal echocardiography in Patient 2. Mid-
oesophaegeal aortic valve long-axis view showing thickening of two
aortic valves and infiltration of the aortomitral junction.
Figure 6 Transoesophageal echocardiography in Patient 2. (A)
Mid-oesophageal right ventricular inflow–outflow view showing
thickened aortic valve leaflets with an additional structure at level of
the non- and right coronary cusp. (B) Mid-oesophaegeal aortic valve
long-axis view showing thickening of two aortic valves and the aor-
tic sinus in continuity with the base of the anterior mitral leaflet. Ao,
aorta; LA, left atrium; lc, left coronary sinus and cusp; LV, left ven-
tricle; nc, non-coronary; rc, right coronary; RV, right ventricle.














tissue with a new aortic regurgitation, but no typical mobile vegeta-
tion, no abscess, and no clear valve destruction.9,10 In both cases,
other sources of infection were excluded and urgent surgery (within
a few days) was performed, mainly because of the severity of the aor-
tic valve regurgitation. Additionally, in the second case, ultrasound
findings were worse within a couple of days, despite antibiotic
treatment.
In the literature, the majority of the patients with a de novo aortic
regurgitation based on GPA necessitates surgical repair. Some cases
had lethal consequences by waiting. Recent overview of valvular in-
volvement in GPA showed a total of 36 case reports. In 41.6% of
cases, it concerned an isolated lesion of the aortic valve. When the
aortic valve is affected, aortic valve replacement was performed in
66.7% of cases. In 8.3%, the lesions were unchanged after immuno-
suppressive therapy, and in another 8.3% of cases, there was an im-
provement or complete resolution after immunosuppressive
therapy.7 Whether recurrence of the disease is possible after surgery
and whether the postoperative follow-up should be different from
the regular postoperative follow-up also remains unclear. Annual
echocardiogram was performed in Patient 2.
Therapeutic management aims to achieve optimal overall disease
control and to minimize treatment-associated toxicity. First-line ther-
apy to rapidly control inflammation are glucocorticoids, while cyclo-
phosphamide and rituximab are the golden standard to induce
remission in severe generalized disease. Methotrexate and azathio-
prine are the current immunosuppressive agents used for mainten-
ance therapy.11,12 Data concerning the effect of medical therapy on
valvular disease caused by GPA seems to be lacking.
Early recognition and diagnosis of GPA is key for an effective and
timely initiation of the appropriate therapy and to prevent the pro-
gression of this disease to an irreversible phase. There are no specific
diagnostic tests for GPA. ENT specialists are often the first clinicians
for patients with GPA, as was the case with our two patients.
Therefore, in cases of atypical inflammation of the ear or sudden sen-
sorineural hearing loss in adults without apparent reason in their
medical history, GPA should be included in the differential diagnosis
of the ENT specialist.13
Conclusion
We report two cases of acute aortic valve regurgitation mimicking in-
fective endocarditis treated with an urgent aortic valve replacement.
In both cases, microscopic findings of the biopsies showed acute and
chronic inflammation with necrosis and necrotizing granulomas, com-
patible with GPA after exclusion of infectious causes. Considering
their recent medical history, clinical findings, serological results, and
histological results, the diagnosis of GPA was made. Granulomatosis
with polyangiitis can be a rare cause of valvular heart disease, most
frequently involving the aortic valve. Acute aortic valve regurgitation
caused by GPA can imitate infective endocarditis and may necessitate
surgical valve replacement. Clinical presentation is often insidious and
lesions of ear, nose, and throat, lung, and/or kidney are most fre-
quently seen. Symptom recognition is important for early diagnosis
and appropriate treatment to prevent further progression of the
disease.
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